Hello, I think it makes sense to have a look at the policy of the PDB concerning obsoleting structures:
The publication is retracted. The associated PDB entry will be obsoleted if requested by the journal. If a request has not been received, the wwPDB will do its best to contact the depositor and co-authors, (former) PIs, journal editors, etc. when made aware of the retraction. If the reason(s) for retraction were such that the associated PDB entry needs to be made obsolete, the wwPDB will obsolete the entry. The citation in the obsoleted entry is the published journal retraction. The structure is incorrect, and the entry author obsoletes the entry. The entry must contain a statement as to the reason for obsoleting the structure. A third-party (such as the employer) requests that the entry is obsoleted (e.g., in case of malfeasance). The citation in the obsoleted entry must be a published explanation and retraction in a peer-reviewed journal. Source: https://www.wwpdb.org/documentation/policy Cheers, Fred. From: CCP4 bulletin board [mailto:[email protected]] On Behalf Of Trevor Sewell Sent: Tuesday, June 27, 2017 8:35 AM To: [email protected] Subject: [ccp4bb] Incorrect Structure in the PDB I have come across a key paper in my field that describes an enzyme mechanism. Their work is based on a deposited structure – by other authors - that is incorrectly interpreted. Is there a process for removing a demonstrably wrong structure (deposited by others) from the PDB and replacing it with a correctly interpreted structure based on the original data? Or is there an alternative, and generally recognized, way of getting the correct structure in the public domain? Many thanks for your advice on this matter. Trevor Sewell Disclaimer - University of Cape Town This e-mail is subject to UCT policies and e-mail disclaimer published on our website at http://www.uct.ac.za/about/policies/emaildisclaimer/ or obtainable from +27 21 650 9111. If this e-mail is not related to the business of UCT, it is sent by the sender in an individual capacity. Please report security incidents or abuse via [email protected]<mailto:[email protected]> ----- Upozornění: Není-li v této zprávě výslovně uvedeno jinak, má tato E-mailová zpráva nebo její přílohy pouze informativní charakter. Tato zpráva ani její přílohy v žádném ohledu Biotechnologický ústav AV ČR, v. v. i. k ničemu nezavazují. Text této zprávy nebo jejích příloh není návrhem na uzavření smlouvy, ani přijetím případného návrhu na uzavření smlouvy, ani jiným právním jednáním směřujícím k uzavření jakékoliv smlouvy a nezakládá předsmluvní odpovědnost Biotechnologického ústavu AV ČR, v. v. i. Disclaimer: If not expressly stated otherwise, this e-mail message (including any attached files) is intended purely for informational purposes and does not represent a binding agreement on the part of Institute of Biotechnology CAS. The text of this message and its attachments cannot be considered as a proposal to conclude a contract, nor the acceptance of a proposal to conclude a contract, nor any other legal act leading to concluding any contract; nor does it create any pre-contractual liability on the part of Institute of Biotechnology CAS
